Cumberland Pharmaceuticals
CPIX
23 hedge funds and large institutions have $3.52M invested in Cumberland Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.
1,767% more call options, than puts
Call options by funds: $56K | Put options by funds: $3K
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
10% more funds holding
Funds holding: 21 → 23 (+2)
0.39% less ownership
Funds ownership: 17% → 16.6% (-0.39%)
26% less capital invested
Capital invested by funds: $4.77M → $3.52M (-$1.25M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$156K |
| 2 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$19K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.99K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$176K |
| 2 |
BlackRock
New York
|
-$31.5K |
| 3 |
Millennium Management
New York
|
-$25.2K |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$20.1K |
| 5 |
Renaissance Technologies
New York
|
-$18.8K |
CPIX Hedge Fund Activity: Q2 2023 in Review
23 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2023, worth a combined $3.52M — down 26% from $4.77M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPIX positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 7 trimmed.
The largest buyer was B. Riley Wealth Advisors, opening a new position worth an estimated $156K. The largest seller was Dimensional Fund Advisors, cutting an estimated $176K.
- 23 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2023, up from 21 in Q1 2023.
- Funds reported $3.52M of Cumberland Pharmaceuticals stock for Q2 2023, down 26% quarter-over-quarter.
- 3 funds opened new Cumberland Pharmaceuticals positions in Q2 2023 and 1 closed out, a net change of +2 holders.
- The largest Cumberland Pharmaceuticals buyer in Q2 2023 was B. Riley Wealth Advisors, an estimated $156K added.
- The largest Cumberland Pharmaceuticals seller in Q2 2023 was Dimensional Fund Advisors, an estimated $176K sold.
Based on aggregated 13F filings for Q2 2023.